Liver Diseases
Welcome,         Profile    Billing    Logout  
 309 Companies   473 Products   473 Products   224 Mechanisms of Action   25 Trials   4900 News 


«12345678910111213...9899»
  • ||||||||||  Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date, Combination therapy:  Budd-Chiari Syndrome in China: Balloon Angioplasty Alone or Combined With Stent Placement? (clinicaltrials.gov) -  Jun 27, 2018   
    P=N/A,  N=88, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | N=48 --> 88 | Trial completion date: Nov 2018 --> Jun 2019 | Trial primary completion date: Oct 2018 --> Sep 2017
  • ||||||||||  Inlyta (axitinib) / Pfizer
    Trial completion:  Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib (clinicaltrials.gov) -  Jun 20, 2018   
    P2,  N=50, Completed, 
    Recruiting --> Active, not recruiting | N=48 --> 88 | Trial completion date: Nov 2018 --> Jun 2019 | Trial primary completion date: Oct 2018 --> Sep 2017 Active, not recruiting --> Completed
  • ||||||||||  Phase classification, Trial completion date, Surgery:  PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection (clinicaltrials.gov) -  Jun 11, 2018   
    P2,  N=64, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Apr 2018 Phase classification: P1/2 --> P2 | Trial completion date: Jun 2018 --> May 2019
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response (clinicaltrials.gov) -  May 4, 2018   
    P=N/A,  N=570, Completed, 
    Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018 Active, not recruiting --> Completed | Trial completion date: Jan 2020 --> Apr 2018 | Trial primary completion date: Jan 2020 --> Apr 2018
  • ||||||||||  Lipotecan (TLC388) / Taiwan Liposome Company
    Trial completion, Enrollment change, Metastases:  Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma (clinicaltrials.gov) -  May 2, 2018   
    P2,  N=30, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=62 --> 30
  • ||||||||||  Trial completion, Trial completion date:  Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases (clinicaltrials.gov) -  Apr 20, 2018   
    P=N/A,  N=40, Completed, 
    Suspended --> Completed | N=10 --> 24 Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2018
  • ||||||||||  oxaliplatin / Generic mfg., doxorubicin hydrochloride / Generic mfg.
    Enrollment change, Trial withdrawal, Metastases:  Combination Treatment for Advanced Liver Cancer (clinicaltrials.gov) -  Apr 19, 2018   
    P3,  N=0, Withdrawn, 
    Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2018 N=98 --> 0 | Completed --> Withdrawn
  • ||||||||||  Trial completion, Trial completion date:  Study for Consolidation Period of Chronic Hepatitis B (clinicaltrials.gov) -  Apr 19, 2018   
    P=N/A,  N=137, Completed, 
    N=63 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Apr 2018
  • ||||||||||  ITX-5061 / iTherX
    Trial completion date, Trial termination, Trial primary completion date:  Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection (clinicaltrials.gov) -  Apr 18, 2018   
    P1,  N=10, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Apr 2018 Trial completion date: Oct 2017 --> Apr 2018 | Active, not recruiting --> Terminated | Trial primary completion date: May 2017 --> Apr 2018; Financial Reasons
  • ||||||||||  Trial completion:  Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis (clinicaltrials.gov) -  Apr 18, 2018   
    P1,  N=6, Completed, 
    Trial completion date: Oct 2017 --> Apr 2018 | Active, not recruiting --> Terminated | Trial primary completion date: May 2017 --> Apr 2018; Financial Reasons Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Phase classification, Trial completion date, IO biomarker:  The Pathogenesis of Hepatitis C Virus Vertical Transmission (clinicaltrials.gov) -  Apr 9, 2018   
    P,  N=38, Completed, 
    Completed --> Terminated; inability to obtain CMS approval Recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: Dec 2018 --> Dec 2017
  • ||||||||||  Phase classification:  The Physiology of Fatigue in Patients With Chronic Liver Disease (clinicaltrials.gov) -  Mar 30, 2018   
    P,  N=12, Completed, 
    Trial completion date: Jan 2018 --> Apr 2018 Phase classification: P=N/A --> P
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Terlipressin Administration in Patients Undergoing Major Liver Resection (clinicaltrials.gov) -  Mar 27, 2018   
    P2,  N=150, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Jun 2017 N=348 --> 150 | Trial completion date: Apr 2019 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Mar 2018
  • ||||||||||  omeprazole / Generic mfg.
    Trial completion date, Trial primary completion date:  Proton Pump Inhibitors and Dysbiosis in Cirrhosis (clinicaltrials.gov) -  Mar 19, 2018   
    P=N/A,  N=60, Completed, 
    N=6000 --> 0 Trial completion date: Nov 2013 --> Feb 2018 | Trial primary completion date: Nov 2013 --> Feb 2018
  • ||||||||||  sorafenib / Generic mfg.
    Trial completion date, Trial termination, Trial primary completion date:  Sorafenib for Hepatopulmonary Syndrome (clinicaltrials.gov) -  Mar 15, 2018   
    P2,  N=28, Terminated, 
    Trial completion date: Nov 2013 --> Feb 2018 | Trial primary completion date: Nov 2013 --> Feb 2018 Trial completion date: Jun 2018 --> Jan 2018 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Jan 2018
  • ||||||||||  sirolimus / Generic mfg.
    Trial completion date, Trial primary completion date, Metastases:  A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Mar 8, 2018   
    P1,  N=64, Active, not recruiting, 
    Phase classification: P2 --> P2/3 Trial completion date: Jul 2018 --> Jul 2019 | Trial primary completion date: Jul 2018 --> Nov 2016
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation (clinicaltrials.gov) -  Mar 7, 2018   
    P=N/A,  N=43, Terminated, 
    Trial completion date: Jul 2018 --> Jul 2019 | Trial primary completion date: Jul 2018 --> Nov 2016 N=300 --> 43 | Trial completion date: Dec 2019 --> Feb 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2018; FDA released requirement to complete study
  • ||||||||||  Trial completion date, Trial termination, Trial primary completion date:  Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization (clinicaltrials.gov) -  Mar 5, 2018   
    P1,  N=57, Terminated, 
    N=165 --> 57 | Recruiting --> Terminated; Low inclusion rate Trial completion date: Jun 2018 --> Apr 2017 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Apr 2017; Logistics regarding PET/CT portion of study
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  MARSPAD: Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure (clinicaltrials.gov) -  Feb 28, 2018   
    P=N/A,  N=34, Completed, 
    Trial primary completion date: Jan 2018 --> Mar 2018 Recruiting --> Completed | N=50 --> 34 | Trial completion date: Dec 2017 --> Sep 2017 | Trial primary completion date: Dec 2017 --> Sep 2017
  • ||||||||||  entecavir / Generic mfg., adefovir dipivoxil / Generic mfg.
    Trial completion, Trial completion date, Trial initiation date, Trial primary completion date, Monotherapy:  IN-US-0205: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B (clinicaltrials.gov) -  Feb 20, 2018   
    P4,  N=102, Completed, 
    Active, not recruiting --> Completed | N=28 --> 16 | Trial primary completion date: Jul 2018 --> Feb 2018 | Trial completion date: Jul 2018 --> Feb 2018 Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2017 | Trial completion date: Feb 2018 --> Sep 2017 | Initiation date: Sep 2012 --> Sep 2012
  • ||||||||||  Avastin (bevacizumab) / Roche
    Trial completion, Trial completion date, Trial initiation date, Trial primary completion date, Combination therapy:  AVAMET: Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer (clinicaltrials.gov) -  Feb 19, 2018   
    P4,  N=83, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2017 | Trial completion date: Feb 2018 --> Sep 2017 | Initiation date: Sep 2012 --> Sep 2012 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Dec 2014 | Trial completion date: Dec 2017 --> Dec 2017 | Initiation date: Nov 2011 --> Nov 2011
  • ||||||||||  sorafenib / Generic mfg.
    Trial completion, Metastases:  Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma (clinicaltrials.gov) -  Feb 14, 2018   
    P2/3,  N=86, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Dec 2014 | Trial completion date: Dec 2017 --> Dec 2017 | Initiation date: Nov 2011 --> Nov 2011 Recruiting --> Completed
  • ||||||||||  Phase classification, Enrollment change, Trial termination, Trial primary completion date, Surgery:  Clinical Application of Image-Guided Liver Surgery (clinicaltrials.gov) -  Feb 13, 2018   
    P2,  N=40, Terminated, 
    Recruiting --> Completed Phase classification: P=N/A --> P2 | N=66 --> 40 | Recruiting --> Terminated | Trial primary completion date: Jun 2015 --> May 2011; The image-guidance system became commercially available
  • ||||||||||  Trial completion, Trial completion date:  Prognosis Factors of Cardiac Complications After Liver Transplantation (clinicaltrials.gov) -  Feb 6, 2018   
    P=N/A,  N=565, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jan 2018
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer (clinicaltrials.gov) -  Feb 1, 2018   
    P1,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jan 2018 N=24 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Sep 2014 --> Feb 2016
  • ||||||||||  Exherin (ADH-1) / Fennec Pharma
    Trial completion, Enrollment change, Trial primary completion date, Surgery, Metastases:  ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (clinicaltrials.gov) -  Jan 30, 2018   
    P1,  N=17, Completed, 
    N=24 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Sep 2014 --> Feb 2016 Recruiting --> Completed | N=24 --> 17 | Trial primary completion date: Dec 2018 --> Jun 2017